Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | PAM | P19021 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2607000 | 1.00 | ALDH1A1 (0.57) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL25822917 | 1.00 | ALDH1A1 (0.57) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL8464631 | 1.00 | ALDH1A1 (0.57) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL2607206 | 0.98 | CYP1A2 (0.57) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL2607005 | 0.91 | CYP1A2 (0.59) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL17450347 | 0.89 | DGKA (0.48) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL13226673 | 0.89 | DGKA (0.48) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL3627923 | 0.89 | DGKA (0.48) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL14010969 | 0.89 | DGKA (0.48) | ALDH1A1DGKACYP1A2ALOX15TDP1 | |
| SCHEMBL8269055 | 0.89 | DGKA (0.48) | ALDH1A1DGKACYP1A2ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3683243-B1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | HANWHA TOTALENERGIES PETROCHEMICAL CO LTD (KR) | 2024-01-24 | — | — | EP | claimed |
| CN-108148153-B | Solid catalyst and method for preparing propylene polymer or copolymer using the same | 韩华道达尔有限公司 | 2021-08-10 | — | — | CN | claimed |
| EP-3683243-A1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | Hanwha Total Petrochemical Co., Ltd. (KR) | 2020-07-22 | — | — | EP | claimed |
| US-4145432-A | 6-ACYLORYALKYL-1,4-DIHYDROPYRIDINE DERIVATIVES AND A METHOD OF EFFECTING VASODILATION THEREWITH | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-20 | — | — | US | claimed |
| EP-3683243-B1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | HANWHA TOTALENERGIES PETROCHEMICAL CO LTD (KR) | 2024-01-24 | — | — | EP | disclosed |
| CN-108148153-B | Solid catalyst and method for preparing propylene polymer or copolymer using the same | 韩华道达尔有限公司 | 2021-08-10 | — | — | CN | disclosed |
| US-10808048-B2 | Process of manufacture of catalyst and propylene polymer that use this or copolymer for propylene polymerization | HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) | 2020-10-20 | — | — | US | disclosed |
| EP-3683243-A1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | Hanwha Total Petrochemical Co., Ltd. (KR) | 2020-07-22 | — | — | EP | disclosed |
| US-20180155461-A1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | HANWHA TOTALENERGIES PETROCHEMICAL CO., LTD. (KR) | 2018-06-07 | — | — | US | disclosed |
| EP-3330299-A1 | PROCESS OF MANUFACTURE OF CATALYST AND PROPYLENE POLYMER THAT USE THIS OR COPOLYMER FOR PROPYLENE POLYMERIZATION | Hanwha Total Petrochemical Co., Ltd. (KR) | 2018-06-06 | — | — | EP | disclosed |
| US-8158640-B2 | Tetrahydroquinoline derivatives and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8158640-B2 | Tetrahydroquinoline derivatives and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20110039828-A1 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
| US-7872126-B2 | Tetrahydroquinoline derivatives and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-7872126-B2 | Tetrahydroquinoline derivatives and a process for preparing the same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20100166826-A1 | BIODEGRADABLE INTRAVAGINAL DEVICES FOR DELIVERY OF THERAPEUTICS | UNIVERSITY OF UATH RESEARCH FOUNDATION (US) | 2010-07-01 | — | — | US | disclosed |
| US-7662773-B2 | which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure | BIOCON LIMITED (IN) | 2010-02-16 | — | — | US | disclosed |
| US-7662773-B2 | which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure | BIOCON LIMITED (IN) | 2010-02-16 | — | — | US | disclosed |
| US-20070082896-A1 | Tetrahydroquinoline derivatives and a process for preparing the same | TANABE SEIYAKU CO., LTD. | 2007-04-12 | — | — | US | disclosed |
| US-20070082896-A1 | Tetrahydroquinoline derivatives and a process for preparing the same | TANABE SEIYAKU CO., LTD. | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082896-A1 | Tetrahydroquinoline derivatives and a process for preparing the same | CETP, MTTP, NPC1L1 | ALDH1A1 3895/4885DGKA 3931/4885CYP1A2 1044/4885 |
| US-20100166826-A1 | BIODEGRADABLE INTRAVAGINAL DEVICES FOR DELIVERY OF THERAPEUTICS | IDUA, MMP1, PGF | ALDH1A1 1134/4885DGKA 2022/4885CYP1A2 2390/4885 |
| US-20110039828-A1 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | CETP, MTTP, NPC1L1 | ALDH1A1 3895/4885DGKA 3931/4885CYP1A2 1044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.